Currency fluctuations
Impact on profitability due to exchange rate changes
- Materiality
- high
CellaVision
CellaVision is a global medical technology company specializing in the development and sale of advanced solutions for the routine analysis of blood and other body fluids. These solutions are crucial for accurate and swift disease diagnosis, particularly for infections and serious cancer diseases. The company's products, which include automated microscopy systems, replace manual laboratory work, enhancing workflow efficiency and skill development in healthcare facilities. Headquartered in Lund, Sweden, CellaVision operates through global partners and local support organizations in over 40 countries.
231
3.98
2.91
| % | |
|---|---|
| Automated Microscopy Systems | 50% Includes systems for analyzing blood and body fluids. |
| Reagents | 20% Consumables used in hematology diagnostics. |
| Software & Other | 30% Digital tools and applications for laboratory workflows. |
CellaVision primarily serves large laboratories and integrated health networks, which require efficient and accurate...
- Large Laboratoriesprimary
Purchase automated systems for efficient diagnostics.
- Integrated Health Networksprimary
Use solutions for accurate disease diagnosis.
- Smaller Hospitalssecondary
Adopt automation to enhance diagnostic capabilities.
CellaVision operates globally, with significant market presence in the Americas, EMEA, and APAC regions...
- •Global operations with headquarters in Lund, Sweden
- •Significant market presence in Americas, EMEA, and APAC
- •Americas driven by demand from large health networks
- •EMEA significant in reagent sales
- •APAC is a growing market for innovative solutions
CellaVision's strategic priorities focus on digitalizing microscopy workflows to enhance diagnostic certainty...
01
Maximize position in large laboratoriesmedium-term
To strengthen market leadership
02
Accelerate adoption of DC-1short-term
To expand market reach
03
Expand leadership in reagentslong-term
To enhance product portfolio
CellaVision faces several risks, including reduced demand, currency fluctuations, and production disruptions...
Production disruptions
Potential supply chain issues affecting product availability
- Materiality
- medium
Revenue recognition
Significant on earnings
Currency effects
Material on financial results
Carasent
CARA.ST · Health Care
Carasent is a Swedish company specializing in digital services for the healthcare industry.
Celularity Inc
CELU · Pharmaceutical Preparations
Celcuity Inc.
CELC · Services-Medical Laboratories
Aura Biosciences, Inc.
AURA · Biological Products, (No Diagnostic Substances)
REVVITY, INC.
RVTY · Laboratory Analytical Instruments
Revvity is a U.S.-based health science company that develops instruments, software, reagents, and services used across research, screening, diagnostics, and reproductive health workflows.
BIOLIFE SOLUTIONS INC
BLFS · Electromedical & Electrotherapeutic Apparatus
: 11/08/2026